The RECOVERY study on hydroxychloroquine was a randomised clinical trial from the UK with a large number of participants and concluded hydroxychloroquine had no

The RECOVERY study on hydroxychloroquine was a randomised clinical trial from the UK with a large number of participants and concluded hydroxychloroquine had no clinical benefit: > "A total of 1542 patients were randomised to hydroxychloroquine and compared with 3132 patients randomised to usual care alone. There was no significant difference in the primary endpoint of 28-day mortality (25.7% hydroxychloroquine vs. 23.5% usual care; hazard ratio 1.11 [95% confidence interval 0.98-1.26]; p=0.10). There was also no evidence of beneficial effects on hospital stay duration or other outcomes." The press release from June: No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19 https://www.recoverytrial.net/news/statement-from-the-chief-investigators-of-the-randomised-evaluation-of-covid-19-therapy-recovery-trial-on-hydroxychloroquine-5-june-2020-no-clinical-benefit-from-use-of-hydroxychloroquine-in-hospitalised-patients-with-covid-19 https://www.recoverytrial.net/news/statement-from-the-chief-...